3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An ethnopharmacology study of Indonesian medicinal plants in Gunung Sari village as dipeptidyl peptidase-IV inhibitor

      , , , , , ,
      Pharmacia
      Pensoft Publishers

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          During an ethnopharmacology study of traditional antidiabetic treatment in Gunung Sari village, Bogor region, Indonesia, fifteen traditional medicinal plants were selected, collected and prepared as crude extracts. Among fifteen plants, only three plants have previously been screened for dipeptidyl peptidase-IV (DPP-IV) inhibitors. Quantitative phytochemical analysis revealed total phenolics content (TPC) ranging from 2.27±0.16 to 5.39±0.05 mg GAE/g extract and total alkaloids content (TAC) from 1.07±0.02 to 4.33±0.07 mg QE/g extract. In-vitro DPP-IV inhibitory activity screening showed that Piper ornatum exhibited the highest inhibition (78.11±1.35 %) and the lowest activity by Syzygium polyanthum (34.30±1.57%) at a concentration of 250 µg/mL, respectively. Analysis of chemical constituents using liquid chromatography-high resolution mass spectrometry (LC-HRMS) indicated at least eleven compounds were present in the crude extract. Among them, several peaks were tentatively assigned as pipcrosides and crocatins, which have previously been isolated from Piper crocatum.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

          Since the year 2000, IDF has been measuring the prevalence of diabetes nationally, regionally and globally.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Techniques for extraction and isolation of natural products: a comprehensive review

            Natural medicines were the only option for the prevention and treatment of human diseases for thousands of years. Natural products are important sources for drug development. The amounts of bioactive natural products in natural medicines are always fairly low. Today, it is very crucial to develop effective and selective methods for the extraction and isolation of those bioactive natural products. This paper intends to provide a comprehensive view of a variety of methods used in the extraction and isolation of natural products. This paper also presents the advantage, disadvantage and practical examples of conventional and modern techniques involved in natural products research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions.

              The incretin effect describes the phenomenon whereby oral glucose elicits higher insulin secretory responses than does intravenous glucose, despite inducing similar levels of glycaemia, in healthy individuals. This effect, which is uniformly defective in patients with type 2 diabetes, is mediated by the gut-derived incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). The importance of the incretin effect for the maintenance of glucose homoeostasis is clearly established, and incretin-based therapies are among the most promising new therapies for type 2 diabetes. However, despite the effectiveness of these therapies in many patients, the idea that they restore the incretin effect is a common misconception. In type 2 diabetes, the endocrine pancreas remains responsive to GLP-1 but is no longer responsive to GIP, which is the most likely reason for a reduced or absent incretin effect. Incretin-based drugs, including GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors, stimulate GLP-1 receptors and thus augment insulin secretion in response to both oral and intravenous glucose stimulation, thereby abolishing any potential difference in the responses to these stimuli. These drugs therefore do not restore the defective incretin effect in patients. By contrast, some bariatric surgical procedures enhance GLP-1 responses and also restore the incretin effect in obese individuals with type 2 diabetes. Thus, not all biological actions elicited by the stimulation of GLP-1 receptors lead to quantitative changes to the incretin effect.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Pharmacia
                PHAR
                Pensoft Publishers
                2603-557X
                0428-0296
                June 05 2023
                June 05 2023
                : 70
                : 2
                : 365-373
                Article
                10.3897/pharmacia.70.e104437
                d61484a4-1d7b-40a1-bdb1-a9c393edd3a0
                © 2023

                http://creativecommons.org/licenses/by/4.0/

                History

                Comments

                Comment on this article